PATENT CLAIM ANALYSIS

Application Number: 16008631
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "326000"]

Abstract:
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein to animals.

Claim (Index 1):
A veterinary compound having a structure of any of the following, or a pharmaceutically acceptable salt thereof:

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.51724
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13841053', '15916752', '13047385', '15181631', '12649161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7373344238238319
- 35 USC 102 Novelty (BERT): 0.4935527101353828
- Combined Prediction Score: 0.712956252454987
- Mean Citation Score: 180.683698
- Max Citation Score: 189.47327
- Similarity Product: 126.25903836957814

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test